chrisvoncsefalvay/vaers-outcomes huggingface dataset:
red rash appeared over legs, abdo & some on arms, on 20MAY93; rash accompanied by itching; poss poison ivy; seen by MD 27MAY93;
On 6JUN92 a rash started on stomach, then face then all over; approx 9AM this started, went to ER 7PM that noc; MD told mom that it was a rxn from shots; no tx given;
Patient received FLUVIRIN at pharmacy on 9/17/11. He came back on 9/19 complaining of itching & swelling in facial area. Told patient we would notify his PCP & in meantime he could take BENADRYL.
Acne breakout on right shoulder and arm (opposite side of where dose is given). I don?t typically break out on my arms. Single raised skin bumps in each location. One on arm appears to be healing after about a week, the other looks inflamed.
Baby would take in a bottle of Enfamil Gentlease and would vomit the entire bottle shortly after. He would vomit sporadically through out the night. He had a bowel movement at 6:00Am 10/27 we thought he was getting better because his fever broke. Later in the day the fever came back he was sweaty had the chills and extremely pale. He had no wet diapers and would refuse a bottle, we also tried pedialyte which he vomited. He was taken to hospital at 6:00 Pm 10/27 and by then he was dry heaving, had a fever, very pale, had no energy to cry while nurses tried to find a vein for an IV. X Ray showed he had intussusception radiologist gave the baby an air enema which opened the intestines back up. He stayed through out the night and was discharged the next day. Between 5:00pm 10/26 and being admitted to the hospital 10/27 at 6:00pm he had only been able to keep down two ounces of formula. It should be noted that two weeks before baby started vomiting we thought he had severe colic and just spit up a lot and would scream for no reason.
On 7/18/11 injection site red, warm and swollen. T 99.3. 5cm erythema and L forearm. Client states arm improving since 7/16/11. Inst to continue ice PRN and return 7/19 if not better. 7/19/11 states "little better".
A 43 year-old female patient with a hand laceration received a right arm (route unknown) injection of DECAVAC, lot number U1958BA, on 21 April 2008 during an emergency room visit. The patient was subsequently evaluated by her physician on 05 November 2008 who diagnosed her with brachial neuritis. Laboratory testing was performed and the results were pending at the time of the report. According to the reporter, the patient initially refused vaccination and emergency room personnel would not discharge the patient without vaccination. Per the reporter, "the patient reacts like this to vaccines". No further information was provided at the time of the report. Documents held by sender: None.
During a review of the internal records, it was found that here might have been a possible temperature excursion with how the vaccine was stored with our mobile vendor.
pt recv vax & exp photophobia, heat sensitivity & chest pains;reporter noted that pt MD felt that sx were not r/t therapy w/vax & refused to report the exp;
Sudden on set of left hand numbness then severe pain, traveled to left foot within 3 weeks , strange sensations on right side of face, extreme fatigue and depression also traveled to right hip by end of June . Orthopedic 5/27/21, emergency room  2times 5/30/21 & 6/15/21, orthopedic  7/20/31 primary car Dr 6/21/21,7/15/21,8/12/21,9/13/21 bloodwork 8/16/21 MRI at hospital 7/27/2 recovery clinic 11/11/21
pressure on her left ear  going down inside the ear canal; jaw on the left side of her face started tingling; lips tingling; lips numb; lips puffy towards the midline; metallic taste; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Aug-2021 and was forwarded to Moderna on 09-Aug-2021.    This spontaneous case was reported by a patient and describes the occurrence of EAR DISCOMFORT (pressure on her left ear  going down inside the ear canal), PARAESTHESIA (jaw on the left side of her face started tingling), PARAESTHESIA ORAL (lips tingling), HYPOAESTHESIA ORAL (lips numb) and LIP SWELLING (lips puffy towards the midline) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced EAR DISCOMFORT (pressure on her left ear  going down inside the ear canal), PARAESTHESIA (jaw on the left side of her face started tingling), PARAESTHESIA ORAL (lips tingling), HYPOAESTHESIA ORAL (lips numb), LIP SWELLING (lips puffy towards the midline) and DYSGEUSIA (metallic taste). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, EAR DISCOMFORT (pressure on her left ear  going down inside the ear canal) and HYPOAESTHESIA ORAL (lips numb) had not resolved and PARAESTHESIA (jaw on the left side of her face started tingling), PARAESTHESIA ORAL (lips tingling), LIP SWELLING (lips puffy towards the midline) and DYSGEUSIA (metallic taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications information was reported.   This case was linked to MOD-2021-281267 (Patient Link).
Started 20 to 30 min after getting the shot. I feel pain and it hurts more when moving pain is from shoulder to elbow 9/17/12.
A general mammogram was performed 28MAR2023 and unusual findings were detected that requires further testing to be performed 23MAY2023.
Mild varicella like eruption about 3 weeks after immunizations. Papules, pustules, and vesicles at different stages of heading on trunk and head. also had fever.
Redness, swelling and pain at injection site starting the day after vaccine. Felt fatigued and body aches as well. The rash at the injection site got bigger and was painful to touch for 1 week then started to heal. 2 weeks after the injection site started to itch again and now resembles a target rash with red on the outside and a central clearing with slight itching but is not painful to touch
I gave patient the Adolescent dose of 0.5 mL instead of adult dose 1.0mL. Notified clinic manager and patient as soon as error was discovered. Patient returned to clinic, was assessed for any adverse reactions and was administered the 2nd 0.5mL dose to make the correct dose. Patient will receive remainder vaccines according to schedule.
Vomiting, shortness of breath, chills, fever, fatigue and heart rate at 140.
Information has been received from a consumer concerning her 22 year old daughter with allergy to iodine and "others unspecified" and a history of migraine who "over 1 year ago" was vaccinated with the first dose of GARDASIL. On an unspecified date the patient was vaccinates with the third dose of GARDASIL. There was no lot number reported. Concomitant therapy included progesterone. "5-6 days after received the vaccine", the patient experienced flu-like symptoms, chills, itching and fatigue. The reporter also stated that the patient developed redness and swelling at the injection site after the third dose of the vaccine. The patient called doctor's office. At the time of the report, the patient had not recovered. Follow-up information has been received from a physician concerning the 22 year old (also reported as 23 year old) female patient with sulfa allergy and no illness at the time of vaccination who on 10-FEB-2010 was vaccinated with the third dose of GARDASIL (lot number 662299/1099Y) into the left deltoid. On 17-FEB-2010 the patient experienced flu-like symptoms, itching and swollen at the injection site. The outcome of the patient was reported as unknown. Additional information has been request.
It feels like I have every possible symptom. After receiving my first dose of Moderna, I had ?covid arm? with a big red welt that then turned into a big itchy rash on the side of my left arm. After my second shot, I immediately felt dizzy, fatigued, and just generally unwell. The next morning, I developed the worst nausea, fever, chills, and diarrhea. My fever increased over the span of about 6 hours until it reached 102 degrees. After the fever broke, I still had a horrible headache but felt so much better. Unfortunately, the fever has come back on the second night post-vaccine and I am at 100 degrees again.
per pt's mom reported on 12DEC95 pt screamed for 6hrs straight (inconsolable), 2hrs p/vax 10OCT95;pt's mom did not call @ time of event, no treatment given;
Fever @103 average, chills, headache, fatigue for  Tuesday 1/12. Upon waking 1/13 low grade fever, went away before returning in the afternoon 99.8, felt tired, took a nap. Woke up from nap @1600 feeling like nothing ever happened. Today, woke up feeling great.   Am actually pleased that I had this reaction. Was told by employer to complete this form. My immune system is working.  Actually feel bad for doing this report, because I don't want the anti vaccine community to take this report the wrong way.
Itching, stinging sensation. Swelling & rash about 3x4 inches around.
Vaccination was not administered correctly/not in the right spot (closer to the acromion process); Tingling in my hand; Hand still numb; A spontaneous report was received from a nurse concerning a female consumer who received Moderna's COVID-19 vaccine (mRNA-1273) that was not administered correctly/not in the right spot (closer to the acromion process)/ Vaccine administered at inappropriate site. The patient subsequently experienced tingling in her hand/paresthesia and her hand was still numb/hypoaesthesia.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included multivitamins and unspecified over the counter medications.  The patient received their first of two planned doses of mRNA-1273 (Lot number: 032L20A) on 07 Jan 2021.  On 03 Feb 2021, prior to the onset of symptoms, the patient received their second of two planned doses of mRNA-1273 (Lot number: 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 03 Feb 2021, the patient reported that the vaccination was not administered correctly and wasn't on the right spot (it was closer to the acromion process). After the vaccination, the patient developed a tingling in her hand that did not hurt but was still numb. No treatment was provided for the events.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The event vaccination was not administered correctly/not in the right spot (closer to the acromion process) was considered resolved on 03 Feb 2021. The outcome of the event tingling in hand and hand still numb was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  However, the causality for the event of vaccine administered at inappropriate site remains as not applicable.
This spontaneous report as received from a certified medical assistant, refers to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported for the patients. On an unspecified date in 2015, starting from and after 03-AUG-2015, the unspecified patients were vaccinated with improperly stored doses of ZOSTAVAX lot # L015417, expiration date 01-AUG-2016 (dose, frequency and route were not reported). No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.
SUPERIOR CEREBELLAR ARTERY SYNDROME ACUTE STROKE OF CEREBELLUM, UNSPECIFIED TYPE AND ARTERY
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: Patient had itchiness at the injection site within 5 min of administration. Patient had redness and slight swelling. He was given 25mg of benadryl and checked up on 15 min after. Patient said the itching went down and the redness decreased. He went home with his partner and confirmed no further issues.
Patient received her vaccination on 1/12/21 administered by pharmacy*+. She expired on 1/12/21 an approximately 7:30pm. Resident did not have any adverse reactions and was a hospice patient.
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 11-JUL-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin) (strength and route were unknown) (lot#  N024562 and expiration date 06-MAR-2019) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
From initial info received on 6/9/05 from an RN regarding an adverse occurring in the USA, it was reported that a 16 year old male pt received his 1st dose of Menactra, lot U1573AC, IM, RA, as well as his 2nd dose of Hep-A, lot AHAVB010AB, IM, LA on 6/6/05. The following day, on 6/7/05, the pt developed an enlarged lymph node with profuse redness and tenderness in the axillary area, which spread across his latissimus dorsal muscle and extended to the chest and nipple area. The pt was seen by a physician. It was not reported whether the pt recovered from these events.
Employee felt nauseated and lightheaded 15 min after immunization. She also had a headache and SOB. She stated that she felt like she had a fever. Her preimmunization temp was 99.2 and post was 97.7, SOB and lightheadedness resolved after 20 mins. Instructed her to call or receive medical attention if symptoms worsen. Employee still has some nausea and a headache.
Local rxn - redness, warm and pain. Systemic rxn - fever and chills.
Information has been requested from a nurse concerning a female physician with no pertinent  medical history or allergies who in 2000 was vaccianted with a first and second dose of varicella virus vaccine, live. Subsequently in 2004, the pt's antibody titer was 0.8 which is less than recommended. There was no product quality complaint involved. Additional information has been requested. Additional information received. The patient's age and date of birth has been added.
Patient received 1st dose of shingrix on 10/30/2019. She experienced soon after pain at injection site. On 1/13/2020 she came in for her 2nd shingrix dose. She reported to the pharmacist that her upper left arm at injection site was still tender. Pharmacist advised patient to call provider.
Administered after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 28-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number TR292, expiry date 3rd November 2025) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th August 2022, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 12-Aug-2022 Reporter's comment: The medical assistant stating that refrigerator temperature log indicated out of range temperatures for Boostrix.   The lowest recorded was 3.7 degrees Celsius and the highest was 9.2 degrees Celsius one day before the vaccination (for 48 minutes).   This case is for 2 out of 10 linked patients reported by same reporter. Additional supportive information: The patient received Boostrix after temperature excursion, which led to incorrect storage of drug.; Sender's Comments:  US-GSK-US2022118568:Same reporter. US-GSK-US2022118570:Same reporter. US-GSK-US2022118571:Same reporter. US-GSK-US2022118572:Same reporter. US-GSK-US2022118612:Same reporter. US-GSK-US2022118613:Same reporter. US-GSK-US2022118614:Same reporter. US-GSK-US2022118615:Same reporter. US-GSK-US2022118616:Same reporter.
Jansen Covid-19 Vaccine EUA,    0130  restless, insomnia, severe chills, sweating, heart racing,      approx 0510. woke up mother stating ?did not feel well & was going to pass out,  anxious, heart racing,  0520. collapsed in bathroom, grazing head against the bathtub, loss of consciousness, profuse sweating,  911 called.    approx. 3-4 minutes of loss of consciousness, waking, but lethargic, confused,  EMT assessment on scene, started IV fluids, transported to hospital -  additional IV fluids, CT scan of head,  EKG, CXR, labs,  given zoltan, pepcid, toradol, monitored for 2-3 hours.  Reported from physician that ?all tests were normal?. Discharged from hospital,  ate few bites of food, coherent but reports no memory of events beyond waking up mother.  Sleeping comfortably
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administration date 18Mar2021 (Batch/Lot number: unknown) at the age of 59 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Shingles (Caller states she also received a shingles and had a bad reaction.), reaction(s): "bad reaction". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 18Mar2021, outcome "unknown", described as "sore arm".  Additional information: Caller states after receiving the vaccine yesterday she has a sore arm last night but otherwise no other side effects. Caller states she also received a shingles and had a bad reaction. Caller is 59 year old female.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
arm got very hard; very painful to touch/ about the size of the palm of her hand; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm got very hard) and PAIN IN EXTREMITY (very painful to touch/ about the size of the palm of her hand) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (arm got very hard) and PAIN IN EXTREMITY (very painful to touch/ about the size of the palm of her hand). At the time of the report, LIMB DISCOMFORT (arm got very hard) and PAIN IN EXTREMITY (very painful to touch/ about the size of the palm of her hand) outcome was unknown.            No concomitant medication were  not provided. No treatment information were  not provided.  The action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-066168 (E2B Linked Report).; Sender's Comments:  MOD-2021-066168:First dose
Hair Loss/ I started losing hair. I have almost none left on the right side of my head.; I feel like I'm on the brink of insanity; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 2, Manufacturer unknown), for Covid-19 immunization; Covid-19 vaccine (Dose 1, Manufacturer unknown), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset Oct2021, outcome "unknown", described as "third shot at the end of October"; ALOPECIA (non-serious) with onset 2021, outcome "not recovered", described as "Hair Loss/ I started losing hair. I have almost none left on the right side of my head."; FEELING ABNORMAL (non-serious) with onset 2021, outcome "not recovered", described as "I feel like I'm on the brink of insanity". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: After third shot at the end of October patient started losing hair and had none left on the right side of head. Patient had hair before these injections and now it's literally going down the drain. Patient have been to the doctor and all blood work came back normal. The patient doesn't go out because the patient was so embarrassed about the appearance. So, in order to save my life I sacrificed my hair and in a sense my life. I'm beyond angry.  The lot number for bnt162b2 was not provided and will be requested during follow up.
I had an oophrectomy 2.5 years ago and I?m on HRT> I have not had a period since then. The night of the vaccine i had spotting which has now progressed to heavy spotting /bleeding and severe cramps. I am taking ibuprofen around the clock and IM toradol with minor relief. This is not acceptable. I have already had COVID and have antibodies and now have to go through this excruciating pain.  Everting out there stating this is stress related is nonsense. Tell that to someone not in the medical field. I?m a nurse. Stress makes you loose your period not have someone without ovaries start bleeding and cramping heavily. This is directly related to the vaccine.